All Episodes

June 10, 2025 28 mins

In Part 3 of our 4-part series on GERD and Barrett’s Esophagus, we’re joined by Dr. Caitlin Houghton, a foregut surgeon with Keck Medicine of USC, to discuss what happens after Barrett’s Esophagus is diagnosed—and how patients can reduce their cancer risk and manage the condition effectively.

From reflux control to endoscopic eradication therapy (EET), and in some cases, surgery, Dr. Houghton breaks down the latest treatment strategies and what patients need to know. This episode offers practical advice, expert insights, and real hope for those navigating life with Barrett’s.

Topics include:

  • What Barrett’s Esophagus is and why it matters

  • How doctors decide when and how to treat

  • The role of EET, medications, and lifestyle changes

  • When surgery may be necessary

  • Tips for patients to advocate for their care

Missed the earlier episodes? Catch up here:
Part 1 – From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer
https://gastrogirl.com/podcast/from-reflux-to-risk-how-heartburn-and-gerd-could-lead-to-esophageal-cancer/

Part 2 – Barrett’s Esophagus: The Hidden Risk of Chronic Heartburn
https://gastrogirl.com/podcast/barretts-esophagus-the-hidden-risk-of-chronic-heartburn/

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers committed to improving patient outcomes.

 

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
24/7 News: The Latest

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.